BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33094683)

  • 1. Deletion of NKX3.1 via CRISPR/Cas9 Induces Prostatic Intraepithelial Neoplasia in C57BL/6 Mice.
    Park JJ; Kim JE; Jeon Y; Lee MR; Choi JY; Song BR; Park JW; Kang MJ; Choi HJ; Bae SJ; Lee H; Kang BC; Hwang DY
    Technol Cancer Res Treat; 2020; 19():1533033820964425. PubMed ID: 33094683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.
    Abdulkadir SA; Magee JA; Peters TJ; Kaleem Z; Naughton CK; Humphrey PA; Milbrandt J
    Mol Cell Biol; 2002 Mar; 22(5):1495-503. PubMed ID: 11839815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T; Schultz D; Hicks J; Hubbard GK; Mutton LN; Lotan TL; Bethel C; Lotz MT; Yegnasubramanian S; Nelson WG; Dang CV; Xu M; Anele U; Koh CM; Bieberich CJ; De Marzo AM
    PLoS One; 2010 Feb; 5(2):e9427. PubMed ID: 20195545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.
    Sharma P; Knowell AE; Chinaranagari S; Komaragiri S; Nagappan P; Patel D; Havrda MC; Chaudhary J
    Mol Cancer; 2013 Jun; 12():67. PubMed ID: 23786676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of glutathione peroxidase 3 induces ROS and contributes to prostatic hyperplasia in Nkx3.1 knockout mice.
    Kim U; Kim CY; Lee JM; Ryu B; Kim J; Bang J; Ahn N; Park JH
    Andrology; 2020 Sep; 8(5):1486-1493. PubMed ID: 32450005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.
    Kim MJ; Bhatia-Gaur R; Banach-Petrosky WA; Desai N; Wang Y; Hayward SW; Cunha GR; Cardiff RD; Shen MM; Abate-Shen C
    Cancer Res; 2002 Jun; 62(11):2999-3004. PubMed ID: 12036903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.
    Kladney RD; Cardiff RD; Kwiatkowski DJ; Chiang GG; Weber JD; Arbeit JM; Lu ZH
    Cancer Res; 2010 Nov; 70(21):8937-47. PubMed ID: 20940396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice.
    Banach-Petrosky W; Ouyang X; Gao H; Nader K; Ji Y; Suh N; DiPaola RS; Abate-Shen C
    Clin Cancer Res; 2006 Oct; 12(19):5895-901. PubMed ID: 17020998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression.
    Vinall RL; Chen JQ; Hubbard NE; Sulaimon SS; Shen MM; Devere White RW; Borowsky AD
    Dis Model Mech; 2012 Nov; 5(6):914-20. PubMed ID: 22563073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
    Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
    Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
    Dutta A; Panja S; Virk RK; Kim JY; Zott R; Cremers S; Golombos DM; Liu D; Mosquera JM; Mostaghel EA; Barbieri CE; Mitrofanova A; Abate-Shen C
    Eur Urol; 2017 Oct; 72(4):499-506. PubMed ID: 28385453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR/Cas9-Mediated Point Mutation in
    Bowen C; Shibata M; Zhang H; Bergren SK; Shen MM; Gelmann EP
    Cancer Res; 2020 Nov; 80(21):4805-4814. PubMed ID: 32943441
    [No Abstract]   [Full Text] [Related]  

  • 14. TNFα-mediated loss of β-catenin/E-cadherin association and subsequent increase in cell migration is partially restored by NKX3.1 expression in prostate cells.
    Debelec-Butuner B; Alapinar C; Ertunc N; Gonen-Korkmaz C; Yörükoğlu K; Korkmaz KS
    PLoS One; 2014; 9(10):e109868. PubMed ID: 25360740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for Nkx3.1 in prostate development and cancer.
    Bhatia-Gaur R; Donjacour AA; Sciavolino PJ; Kim M; Desai N; Young P; Norton CR; Gridley T; Cardiff RD; Cunha GR; Abate-Shen C; Shen MM
    Genes Dev; 1999 Apr; 13(8):966-77. PubMed ID: 10215624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the Nkx3.1 gene in mice results in morphogenetic defects of minor salivary glands: parallels to glandular duct morphogenesis in prostate.
    Schneider A; Brand T; Zweigerdt R; Arnold H
    Mech Dev; 2000 Jul; 95(1-2):163-74. PubMed ID: 10906459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nkx3.1, a murine homolog of Ddrosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands.
    Tanaka M; Komuro I; Inagaki H; Jenkins NA; Copeland NG; Izumo S
    Dev Dyn; 2000 Oct; 219(2):248-60. PubMed ID: 11002344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun.
    Riedel M; Berthelsen MF; Cai H; Haldrup J; Borre M; Paludan SR; Hager H; Vendelbo MH; Wagner EF; Bakiri L; Thomsen MK
    Oncogene; 2021 Apr; 40(13):2437-2447. PubMed ID: 33674748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancer.
    Häussler O; Epstein JI; Amin MB; Heitz PU; Hailemariam S
    Hum Pathol; 1999 Sep; 30(9):1077-86. PubMed ID: 10492043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.